The feds have busted 12 shady STD treatment companies—and the Better Business Bureau might be collateral damage
The Food and Drug Administration and the Federal Trade Commission joined forces Tuesday to threaten 12 companies with legal action over the manufacture and sale of products that purport to treat sexually transmitted diseases. The FDA's webpage alone, complete with the video STD Treatments That Don't Work, will prove a devastating assault to most of these businesses. Though it lacks the authority to carry out an IRS-style raid, the FDA has been using its legal department's fearsome prose to bust bad drugs sold as supplements for decades now, and in the past few years we've seen the agency ramp up these efforts as online commerce has driven the problem to epidemic proportions.
So while I expect a steady drumbeat of deadbeat drug bashing, I was instead far more interested to discover a prominent consumer rights nonprofit linked to the mess. The Better Business Bureau lent its considerable credibility to one of the companies the Feds are slamming for endangering the country's public health. What's more, the BBB followed its normal practices and policies in doing so, the organization told me yesterday.
The BBB's involvement became apparent once I decided to take a closer look at the assortment of crappy capsules the Feds are putting on notice. I zeroed in on Medavir, produced by a central-Florida based outfit called The Arenson Group (a.k.a. TAG Health). The internet is littered with TAG's websites selling Medavir under various names. While scrolling along you'll see the usual unsubstantiated claims and endorsements from unnamed physicians that one would expect from shady operators. "Over 90% of outbreaks do not occur when you apply Medavir at first signs of outbreak," one site says. Stop the presses! For your information, that compares to about an 50 to 60 percent chance of future genital herpes outbreaks while on FDA-approved medical treatment (versus a blistering 80 to 90 percent rate without treatment) according to a 2007 meta-analysis of available trial data.
The Arenson Group preys on ashamed kids and unsophisticated adults. Your sexual partner, your doctor, and the public health department need never know!
So how's the the BBB mixed up in this? Take a look at this screen shot from one of the Medavir sites:
As shown in the above screenshot, Medavir prominently displays its BBB Accredited Business logo in the upper left hand corner of its website. Unlike the sprinkling of other certifications and logos on the site that turn out to be illegitimate, BBB's is the real deal. Until earlier today when the organization heard from me and took down their rating, consumers could click on that link to see its A+ rating from the BBB:
The BBB accredited The Arenson Group in January 2009 "based on information provided by the company and our own research," says Holly Salmons, Vice President of BBB of Central Florida.
The bottom line? The BBB is pleased to accredit questionable pill purveyors when they market their mixtures as supplements. Because The Arenson Group's website included the statement "none of these statements have been fully evaluated by the FDA" at the time they applied for accreditation (it still does), the BBB was satisfied to welcome them into its brotherhood of legitimate American businesses. In fact, Ms. Salmons says that while as of Wednesday she has frozen Arenson's status in "update" mode, the BBB will suspend or restore their accreditation only pending their response to the FDA's demands.
Arenson could potentially satisfy federal regulators by removing all medical claims from its websites and packaging and marketing Medavir in some vague manner unconnected to treating herpes sufferers. That would leave little text on their sites indeed. I find it difficult to imagine what a website attempting to sell Medavir without claiming that it treats herpes would look like (what in the world is a "herpes supplement"?), and I'd love to see the original materials the BBB reviewed in 2009.
Once BBB approved Medavir's membership, the company wasn't slated for another review for three years, giving plenty of time for its claims to become progressively more egregious without any oversight. But lack of such frequent review doesn't seem to be the crux of the problem in my own analysis. BBB protests to me that Medavir's January 2009 materials fit classification as a supplement and did not overstep bounds into FDA-regulated territory. After reviewing versions of Medavir.com from January 2009 and the oldest available version from June 2008 over at the Internet Archive, I don't buy their version of events. Take a look back, and make your own call.
The Arenson Group showed off its A+ BBB rating to its vulnerable lot of prospective consumers as an implied seal of approval. This use, even for a health care product, is routine in BBB practice. "Accredited Businesses are permitted to report their rating as long as it is accurate at all times," BBB VP Salmons tells me. Arenson had just two complaints over three years, she says, which is a low complaint volume. Another BBB policy helps explain why Medavir might have so few complaints. BBB only accepts complaints that come with real names and documentation.
People searching out genital herpes cures from the privacy of their own homes are obviously reluctant or unable to do so in the care of actual medical professionals out there in the real world. These consumers must have found some reassurance in BBB's A+ rating, which is why the Medavir site advertised it high above the fold. Medavir had a perfectly marginalized population base from which to draw its A+ record: folks too anxiety-ridden to speak up once they realized they'd been scammed; STD sufferers who didn't think admitting they have herpes to a third party was worth it when that third party took the Hippocratic Oath certainly aren't going to confide their private secrets to the BBB.
The characters behind Medavir made BBB into a Bogus Balms Bureau. To get out of this fix, BBB needs to eject itself from the field of lending credibility to unregulated drug makers entirely. This means excluding health "supplements." It's hard enough for physicians and the FDA to weigh evidence about these agents. BBB ratings are bestowed by an organization with no possible claim to competence in mediating between patients and providers in the unique health care marketplace, as the policies that led to this case prove. Moreover, BBB ratings add nothing of value to any consumer considering what pills to take for an illness. Continuing to offer accreditation to firms like The Arenson Group (aka Medavir Medical Advances) of Windmere, Florida, whether or not they barely skirt FDA enforcement does a disservice to BBB's own heritage.
“Here is what I would like for you to know: In America, it is traditional to destroy the black body—it is heritage.”
Last Sunday the host of a popular news show asked me what it meant to lose my body. The host was broadcasting from Washington, D.C., and I was seated in a remote studio on the Far West Side of Manhattan. A satellite closed the miles between us, but no machinery could close the gap between her world and the world for which I had been summoned to speak. When the host asked me about my body, her face faded from the screen, and was replaced by a scroll of words, written by me earlier that week.
The host read these words for the audience, and when she finished she turned to the subject of my body, although she did not mention it specifically. But by now I am accustomed to intelligent people asking about the condition of my body without realizing the nature of their request. Specifically, the host wished to know why I felt that white America’s progress, or rather the progress of those Americans who believe that they are white, was built on looting and violence. Hearing this, I felt an old and indistinct sadness well up in me. The answer to this question is the record of the believers themselves. The answer is American history.
In Sunday’s referendum, voters firmly rejected Europe’s plan to bail out the country’s economy. What’s next?
Updated on July 5, 2015 4:57 pm
On Sunday, Greek citizens took to the polls in a controversial referendum asking them whether they support a plan calling for continued economic austerity in exchange for debt relief. Their answer—with more than 70 percent of the votes counted—was a resounding “no.”The outcome means that next steps for the nation, which has fallen into arrears with the IMF and imposed capital controls to prevent a run on the banks, is largely uncertain. According to reports from Reuters, the country may next attempt to secure financing by asking for more emergency funding from the European Central Bank.
The referendum—which had asked Greeks to vote “yes” or “no” on a proposal from Eurogroup leaders to extend financing to the deeply indebted country— was called for by Greek Prime Minister Alexis Tsipras amid meetings of Eurozone leaders trying to come up with a deal to allow the country to avoid default. The call for the referendum effectively ended those discussions.
Defining common cultural literacy for an increasingly diverse nation
Is the culture war over?
That seems an absurd question. This is an age when Confederate monuments still stand; when white-privilege denialism is surging on social media; when legislators and educators in Arizona and Texas propose banning ethnic studies in public schools and assign textbooks euphemizing the slave trade; when fear of Hispanic and Asian immigrants remains strong enough to prevent immigration reform in Congress; when the simple assertion that #BlackLivesMatter cannot be accepted by all but is instead contested petulantly by many non-blacks as divisive, even discriminatory.
And that’s looking only at race. Add gender, guns, gays, and God to the mix and the culture war seems to be raging along quite nicely.
One reason for the continued resistance to the Affordable Care Act is a badly distorted narrative of how it became law.
The U.S. Supreme Court’s remarkable 6-3 decision in King v. Burwell saves the Affordable Care Act from evisceration, although Obamacare will undoubtedly face a continuing pattern of guerrilla attacks from Congress, the courts, and Republican governors and state legislatures. Still, as many observers have pointed out, the core elements of the plan, including the exchanges, the subsidies, the individual mandate, the expansion of coverage in family plans to children 26 and under, and the elimination of lifetime limits and of preexisting conditions as bars to coverage, are almost certainly here to stay.
This is, of course, a huge victory for President Obama. But the passage, implementation, and ratification of Obamacare continue to be plagued by a widespread belief that it was tarnished by the way it was proposed and debated. A raft of reporters, commentators, and politicians argue that the president made a huge mistake in taking up healthcare at the beginning of his term, before building relationships of trust with Republicans, and then compounded that error by jamming it through quickly without any Republican input or efforts to find common ground.
The show reveals what happened to Ray, while Bezzerides and Woodrugh investigate the mayor, and Frank indulges in some amateur dentistry.
Orr: More than a third of the way into this season of True Detective, I’d say that the two best scenes so far were adjacent ones, albeit ones in consecutive episodes: the last scene of episode two—the man in the bird mask appearing out of nowhere, the stunning (apparent) death of a principal character as the radio plays “I Pity the Fool”—and the first scene of tonight’s episode: Ray and his father in the bar, and yet clearly someplace else altogether, someplace otherworldly. “Where is this?” Ray asks. His dad replies, “I don’t know. You were here first.” Is this Ray’s dying vision? Is he a ghost who will watch the season unfold from beyond the grave?
In 1992, the neuroscientist Richard Davidson got a challenge from the Dalai Lama. By that point, he’d spent his career asking why people respond to, in his words, “life’s slings and arrows” in different ways. Why are some people more resilient than others in the face of tragedy? And is resilience something you can gain through practice?
The Dalai Lama had a different question for Davidson when he visited the Tibetan Buddhist spiritual leader at his residence in Dharamsala, India. “He said: ‘You’ve been using the tools of modern neuroscience to study depression, and anxiety, and fear. Why can’t you use those same tools to study kindness and compassion?’ … I did not have a very good answer. I said it was hard.”
New data shows that students whose parents make less money pursue more “useful” subjects, such as math or physics.
In 1780, John Adams wrote a letter to his wife, Abigail, in which he laid out his plans for what his children and grandchildren would devote their lives to. Having himself taken the time to master “Politicks and War,” two revolutionary necessities, Adams hoped his children would go into disciplines that promoted nation-building, such as “mathematicks,” “navigation,” and “commerce.” His plan was that in turn, those practical subjects would give his children’s children room “to study painting, poetry, musick, architecture, statuary, tapestry, and porcelaine.”
Two-hundred and thirty-five years later, this progression—“from warriors to dilettantes,” in the words of the literary scholar Geoffrey Galt Harpham—plays out much as Adams hoped it would: Once financial concerns have been covered by their parents, children have more latitude to study less pragmatic things in school. Kim Weeden, a sociologist at Cornell, looked at National Center for Education Statistics data for me after I asked her about this phenomenon, and her analysis revealed that, yes, the amount of money a college student’s parents make does correlate with what that person studies. Kids from lower-income families tend toward “useful” majors, such as computer science, math, and physics. Those whose parents make more money flock to history, English, and performing arts.
The unwillingness of the former secretary of state to take questions from the press contrasts sharply with Jeb Bush’s marked affinity for public disclosure.
Howard Kurtz reported on Sunday night that the Hillary Clinton campaign has decided to open itself to more press interviews. Kurtz quoted the campaign’s communications director, Jennifer Palmieri: “By not doing national interviews until now, Palmieri concedes, ‘we’re sacrificing the coverage. We’re paying a price for it.’”
Meanwhile Jeb Bush chatted July 2 with the conservative website, the Daily Caller. The Daily Caller interview broke an unusually protracted no-interview period for Bush. It had been more than two weeks since he appeared on the Tonight show with Jimmy Fallon. Bush spoke that same day, June 17, to Sean Hannity’s radio show and ABC News. Five days earlier, he’d spoken to Germany’s Der Spiegel—altogether, five interviews in the month of June. That brought his total, since the beginning of February, to 39, according to the Bush campaign.*
The Islamic State is no mere collection of psychopaths. It is a religious group with carefully considered beliefs, among them that it is a key agent of the coming apocalypse. Here’s what that means for its strategy—and for how to stop it.
What is the Islamic State?
Where did it come from, and what are its intentions? The simplicity of these questions can be deceiving, and few Western leaders seem to know the answers. In December, The New York Times published confidential comments by Major General Michael K. Nagata, the Special Operations commander for the United States in the Middle East, admitting that he had hardly begun figuring out the Islamic State’s appeal. “We have not defeated the idea,” he said. “We do not even understand the idea.” In the past year, President Obama has referred to the Islamic State, variously, as “not Islamic” and as al-Qaeda’s “jayvee team,” statements that reflected confusion about the group, and may have contributed to significant strategic errors.
For centuries, experts have predicted that machines would make workers obsolete. That moment may finally be arriving. Could that be a good thing?
1. Youngstown, U.S.A.
The end of work is still just a futuristic concept for most of the United States, but it is something like a moment in history for Youngstown, Ohio, one its residents can cite with precision: September 19, 1977.
For much of the 20th century, Youngstown’s steel mills delivered such great prosperity that the city was a model of the American dream, boasting a median income and a homeownership rate that were among the nation’s highest. But as manufacturing shifted abroad after World War II, Youngstown steel suffered, and on that gray September afternoon in 1977, Youngstown Sheet and Tube announced the shuttering of its Campbell Works mill. Within five years, the city lost 50,000 jobs and $1.3 billion in manufacturing wages. The effect was so severe that a term was coined to describe the fallout: regional depression.